Vasitis nodosa is a benign proliferation of vas deferens epithelium, thought to be a response to trauma or obstruction, usually vasectomy. Although histologic features mimic malignancy, diagnosis is usually straightforward due to the clinical context. We analyzed 21 specimens with vasitis or epididymitis nodosa with antibodies to PAX8, CD10, p63, alpha-methyl-acyl-coA-racemase (AMACR), GATA3, prostein, NKX3.1, and prostatespecific antigen (PSA). Two diagnostically problematic cases included 1) florid bladder muscle involvement after prostatectomy and 2) involvement of the ampulla and ejaculatory duct in a radical prostatectomy specimen. Vasitis nodosa was excluded in 3 additional histologic mimics (2 post-treatment prostate cancers and 1 bladder cancer). PAX8 yielded consistent positive (100%) nuclear staining in the proliferative glands of vasitis nodosa, often stronger and more uniform than native vas deferens. CD10 labeling was common but also labeled secretions and other structures. Labeling for p63 was often basally located in glands with a multilayered appearance, but often markedly attenuated or lacking in the proliferative glands compared to native epithelium. AMACR positivity was variable but often present (19/21). PSA, prostein, and NKX3.1 were consistently negative. Rare problematic cases of vasitis nodosa include "invasion" of the ejaculatory duct at the prostate and involvement of bladder muscle after prostatectomy. The proliferative vasitis nodosa glands often have a prostate cancer-like staining pattern with variable AMACR positivity and negative or patchy p63. However, reliable positivity for PAX8, patchy GATA3, and negative staining for PSA, NKX3.1, and prostein aid in distinguishing from prostate cancer and tubular variants of bladder cancer.
Introduction
Vasitis nodosa is a benign proliferation of vas deferens epithelium, thought to occur as a response to mechanical obstruction or traumatic injury. It is hypothesized that mechanical obstruction leads to increased intraluminal pressure and resulting spermatic fluid leakage. This extravasation of fluid is thought to result in subsequent inflammation and glandular proliferation. Vasitis nodosa typically occurs in the setting of prior vasectomy, but has been reported in other clinical scenarios, such as trauma, primary infertility, cystitis, or surgery. Clinical findings can include palpable nodules, scrotal pain, or swelling [1] [2] [3] [4] .
In the usual clinical context (characteristically post-vasectomy), vasitis nodosa is a relatively straightforward diagnosis, despite that it is known to have worrisome histologic characteristics, such as prominent nucleoli, pseudoinvasive growth pattern, and vascular and perineural invasion [5] [6] [7] [8] . However, we have encountered rare clinical scenarios in which vasitis nodosa presented a diagnostic challenge, including occurrence at the ampulla of the vas deferens (the tortuous and dilated segment at the junction with the prostate and ejaculatory duct) in a prostate cancer specimen and in the wall of a cystectomy specimen after radical prostatectomy. Conversely, we have encountered occasional cancers that raised morphologic consideration of vasitis nodosa in these sites. Although a few immunohistochemical markers have been previously studied vasitis nodosa, we sought to characterize the immunohistochemical staining pattern of vasitis nodosa with a modern antibody panel to aid in such scenarios.
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Materials and Methods
After approval by the Institutional Review Board of the Henry Ford Health System, we queried the databases at two academic health systems (Indiana University Health and Henry Ford Health System) for cases of vasitis nodosa, epididymitis nodosa, and sperm granuloma, yielding 29 specimens. These cases were reviewed, of which 21 from 18 patients were ultimately confirmed to have vasitis or epididymitis nodosa and were included in the final cohort.
The specimens were from primarily vasectomy, vasovasostomy, or excisional biopsy samples, whereas 2 of the problematic diagnoses were found in resection specimens
(1 radical prostatectomy and 1 cystectomy). Three cancer specimens (2 prostate cancers and 1 bladder cancer) for which morphology raised consideration of vasitis nodosa were also studied. Each specimen was fixed in 10% formalin solution and embedded in paraffin wax. Sections of 4-micron thickness were cut, stained with hematoxylin and eosin, and microscopically examined. 
Vasitis nodosa mimics
Three cancers for which vasitis nodosa was considered in the differential diagnosis were also studied, including 2 post-treatment prostate cancers ( PAX8 is a member of the paired box family of genes, and it is involved in the development of tissues of the Wollfian (mesonephric) duct, kidney, Mullerian organs, and the thyroid [11] . As the vas deferens is a Wolffian structure [12] , the positivity for PAX8
confirmed by this study may be of value in distinguishing vasitis nodosa from other epithelial proliferations, such as prostate cancer or a bladder cancer variant. PAX8 has been demonstrated to be consistently negative in adenocarcinoma of the prostate, and usually negative in urothelial carcinomas [13] [14] [15] . Other studies have noted PAX8 positivity in the normal vas deferens [11, 12] , and PAX2 labeling in related structures [16] .
However, it is interesting that in the current study of vasitis nodosa, the staining characteristics of the proliferative vasitis nodosa glands differ somewhat from that of the normal vas deferens, particularly in that PAX8 labeling was sometimes stronger and more uniform and that GATA3 and p63 labeling can be decreased or absent. GATA3 is a transcription factor with critical roles in a variety of tissues [17] , including development of Wolffian duct structures [18] . It has been recently found to be a helpful marker, although multispecific, for a variety of tumors, especially urothelial carcinoma and breast carcinoma, with consistent negative staining in prostate cancer [19] [20] [21] .
This study also reveals a previously undocumented potential diagnostic pitfall in this differential diagnosis. The combination of AMACR positivity and absence of basal cells with p63 staining is frequently employed in the diagnosis of prostate cancer. A
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Indeed, 2 cases included in the studied occurred in scenarios where prostate cancer was a major consideration, 1 in a radical prostatectomy for cancer, in which the proliferation occurred ampulla of the vas deferens (the tortuous and dilated segment at the junction with the prostate and ejaculatory duct), mimicking seminal vesicle invasion (pT3b disease) and 1 in a cystectomy specimen for radiation cystitis after prostatectomy, in which the proliferation mimicked recurrent cancer invading bladder wall. To our knowledge, these scenarios have not been previously reported, but they may represent uncommon contexts in which a proliferation of vas deferens occurs due to transection (in the case of prior prostatectomy) or obstruction (for unknown reasons in the radical prostatectomy case).
Occurrence at the prostate is likely quite rare, as we identified only 1 case from hundreds of radical prostatectomy specimens evaluated in our institution annually, although it is also possible that subtle forms are underrecognized.
Other considerations that may be entertained for vasitis nodosa involving the bladder wall include deceptive urothelial carcinoma variants [22, 23] , such as urothelial carcinoma with small tubules [24, 25] , or microcytic urothelial carcinoma [26, 27] . This difficulty could be further compounded by the fact that vasitis nodosa can be GATA3 and A C C E P T E D M A N U S C R I P T 
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